US 12171758
Crystalline salt forms of kappa opioid receptor antagonist and products and methods related thereto
granted A61KA61K31/4709A61P
Quick answer
US patent 12171758 (Crystalline salt forms of kappa opioid receptor antagonist and products and methods related thereto) held by Neumora Therapeutics, Inc. expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Neumora Therapeutics, Inc.
- Grant date
- Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/4709, A61P, A61P25/06, A61P25/18